Viewing SEC Facts Units
Company Name:
Qualigen Therapeutics, Inc.
CIK:
1460702
Start Filing Date:
2022-05-23
End Filing Date:
2022-05-26
ACCN:
0001493152-23-041230
Value:
$ 346,896
Value Error:
$ None
Created By:
Date Filed:
2023-11-14
FY:
2023
Fiscal Period:
Q3
Frame:
CY2023Q3I
Type:
us-gaap
Form:
10-Q
Units:
shares